These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24513926)

  • 1. Methotrexate embryopathy after exposure to low weekly doses in early pregnancy.
    Martín MC; Barbero P; Groisman B; Aguirre MÁ; Koren G
    Reprod Toxicol; 2014 Jan; 43():26-9. PubMed ID: 24513926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
    Weber-Schoendorfer C; Chambers C; Wacker E; Beghin D; Bernard N; ; Shechtman S; Johnson D; Cuppers-Maarschalkerweerd B; Pistelli A; Clementi M; Winterfeld U; Eleftheriou G; Pupco A; Kao K; Malm H; Elefant E; Koren G; Vial T; Ornoy A; Meister R; Schaefer C
    Arthritis Rheumatol; 2014 May; 66(5):1101-10. PubMed ID: 24470106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.
    Weber-Schoendorfer C; Hoeltzenbein M; Wacker E; Meister R; Schaefer C
    Rheumatology (Oxford); 2014 Apr; 53(4):757-63. PubMed ID: 24369411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature.
    Ostensen M; Hartmann H; Salvesen K
    J Rheumatol; 2000 Aug; 27(8):1872-5. PubMed ID: 10955326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniosynostosis Following Fetal Methotrexate Exposure.
    Zarella CS; Albino FP; Oh AK; Wood BC; Oluigbo CO; Myseros JS; Magge SN; Keating RF; Rogers GF
    J Craniofac Surg; 2016 Mar; 27(2):450-2. PubMed ID: 26890458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult and two children with fetal methotrexate syndrome.
    Bawle EV; Conard JV; Weiss L
    Teratology; 1998 Feb; 57(2):51-5. PubMed ID: 9562676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pregnancy outcome after preconceptional exposure to methotrexate for ectopic pregnancy].
    Lagarce L; Bernard N; Carlier P; Phelipot-Lates S; Perault-Pochat MC; Drablier G; Bourneau-Martin D; Lainé-Cessac P;
    Therapie; 2016 Sep; 71(4):389-94. PubMed ID: 27203166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of methotrexate in young patients with respect to the reproductive system.
    Gromnica-Ihle E; Krüger K
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S80-4. PubMed ID: 21044438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
    Chakravarty EF; Sanchez-Yamamoto D; Bush TM
    J Rheumatol; 2003 Feb; 30(2):241-6. PubMed ID: 12563675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratogen update: methotrexate.
    Hyoun SC; Običan SG; Scialli AR
    Birth Defects Res A Clin Mol Teratol; 2012 Apr; 94(4):187-207. PubMed ID: 22434686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose and high-dose methotrexate are two different drugs in practical terms.
    Malaviya AN; Sharma A; Agarwal D; Kapoor S; Garg S; Sawhney S
    Int J Rheum Dis; 2010 Oct; 13(4):288-93. PubMed ID: 21199463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy.
    Poggi SH; Ghidini A
    Fertil Steril; 2011 Sep; 96(3):669-71. PubMed ID: 21733506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.
    Østensen M; von Esebeck M; Villiger PM
    J Rheumatol; 2007 Jun; 34(6):1266-9. PubMed ID: 17516615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding).
    Martínez Lopez JA; Loza E; Carmona L
    Clin Exp Rheumatol; 2009; 27(4):678-84. PubMed ID: 19772806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
    Viktil KK; Engeland A; Furu K
    Scand J Rheumatol; 2012 May; 41(3):196-201. PubMed ID: 22401133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events in methotrexate-treated rheumatoid arthritis patients.
    Sandoval DM; Alarcón GS; Morgan SL
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():49-56. PubMed ID: 8535650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
    Gilani ST; Khan DA; Khan FA; Ahmed M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methotrexate: safe if prescribed correctly].
    Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A
    Ned Tijdschr Geneeskd; 2009; 153():A695. PubMed ID: 19785857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
    J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.